Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Type 1 Diabetes Mellitus and Diabetic Nephropathy

NCT06115460 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06115460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06115460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Type 1 Diabetes Mellitus and Diabetic Nephropathy
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2022
Completion date
June 15, 2023
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetic nephropathy